Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies
- 31 August 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8766) , 535-538
- https://doi.org/10.1016/0140-6736(91)91100-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Improved methodology for analyzing local and distant recurrence.Journal of Clinical Oncology, 1990
- Second Cancer Following Chemotherapy and Radiotherapy: An epidemiological perspectiveActa Oncologica, 1990
- Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapyCancer, 1989
- Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trialsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- The Stockholm trial on adjuvant tamoxifen in early breast cancerBreast Cancer Research and Treatment, 1987
- A method of analysis taking into account competing events: Application to the study of digestive complications following irradiation for cervical cancerStatistics in Medicine, 1987
- Second malignancies after CMF for resectable breast cancer.Journal of Clinical Oncology, 1987
- Second Neoplasms After Adjuvant Chemotherapy for Operable Breast CancerAmerican Journal of Clinical Oncology, 1986
- Breast cancer and acute leukemia: Report of 24 cases and review of the literatureAmerican Journal of Hematology, 1978